This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A new molecule, if administered alongside antipsychotics, can activate dopamine receptors in the pancreas, limiting metabolic disruptions.
Antipsychotics pose greater health risks than previously understood, leading to severe complications in dementia patients.
Bethany Yeiser is now free of severe schizophrenia symptoms after starting clozapine in 2008, allowing her to graduate college and start the CURESZ Foundation.
For medical professionals, the FDA’s move raises troubling questions about efficacy, safety, and regulatory diligence.
